Adult Cardiac Literature Watch - First Quarter 2008

Duration of red-cell storage and complications after cardiac surgery.
Koch CG, Li L, Sessler DI, et al.
N Eng J Med 2008;358:1229-39.

Contemporary standards for the diagnosis and treatment of heparin-induced thrombocytopenia (HIT).
Baldwin ZK, Spitzer AL, Ng VL, Harken AH.
Surgery 2008;143:305-12.

Myths about surgical myectomy: rumors of its death have been greatly exaggerated.
Maron BJ, Ommen SR, Nishimura RA, et al.
Am J Cardiol 2008;101:887-89.

Cardiogenic shock: current concepts and improving outcomes.
Reynolds HR, Hochman JS.
Circulation 2008;117:686-97.

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.
Gilard M, Arnaud B, Cornily JC, et al.
J Am Coll Cardiol 2008;51:256-60.

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.
The Amadeus Investigators.
Lancet 2008;371:315-21.

The effect of Aprotinin on outcome after coronary-artery bypass grafting.
Shaw AD, Stafford-Smith M, White WD, Phillips-Bute B, et al.
N Eng J Med 2008;358:784-93.

Aprotinin during coronary-artery bypass grafting and risk of death.
Schneeweiss S, Seeger JD, Landon J, Walker AM.
N Eng J Med 2008;358:771-83.

Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
Rouleau JL, Warnica WJ, Baillot R, et al.
Circulation 2008; 117:24-31.

Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study.
Karkouti K, Wijeysundera DN, Beattie WS, et al.
Circulation 2008;117:478-84.

Cardiac tumours: an update.
Burke A, Jeudy J, Virmani R.
Heart 2008;94:117-23.

Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization.
Buszman PE, Kiesz SR, Bochenek A, et al.
J Am Coll Card 2008;51:538-45.

Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.
Hannan EL, Wu C, Walford C, et al.
N Engl J Med 2008;358:331-41.

Patients with non–ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.
Chew DP, Huang Z, Pieper KS, et al.
Am Heart J 2008;155:239-44.

Outcomes of 1,090 consecutive, elective, nonselected percutaneous coronary interventions at a community hospital without onsite cardiac surgery.
Frutkin AD, Mehta SK, Patel T, et al.
Am J Cardiol 2008;101:53-57.

Clinical characteristics and in-hospital outcomes of patients with cardiogenic shock undergoing coronary artery bypass surgery: insights from the Society of Thoracic Surgeons national cardiac database.
Mehta RH, Grab JD, O’Brien SM, et al.
Circulation 2008;117:876-85.

Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study.
Chocron S, Baillot R, Rouleau JL, et al.
Eur Heart J 2008;29:673-79.

Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery.
Kim YM, Kattach H, Ratnatunga C, Pillai R, Channon KM, Casade B.
J Am Coll Cardiol 2008;51:68-74.

Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery.
Echahidi N, Pibarot P, O’Hara G, Mathieu P.
J Am Coll Card 2008;51:793-801.

Short and midterm results with minimally invasive endovascular repair of acute and chronic thoracic aortic pathology.
Brown KE, Eskandari MK, Matsumura JS, Rodriguez H, Morasch MD.
J Vasc Surg 2008;47:714-23.

International controlled clinical trial of thoracic endovascular aneurysm repair with the Zenith TX2 endovascular graft: 1-year results.
Matsumura JS, Cambria RP, Dake MD, Moore RD, Svensson LG, Snyder S.
J Vasc Surg 2008; 47:247-57.

Constrictive pericarditis in the modern era: novel criteria for diagnosis in the cardiac catheterization laboratory.
Talreja DP, Nishimura RA, Oh JK, Holmes DR.
J Am Coll Card 2008;51:315-19.

Mayo clinic risk score for percutaneous coronary intervention predicts in-hospital mortality in patients undergoing coronary artery bypass graft surgery.
Singh M, Gersh BJ, Li S, et al.
Circulation 2008;117:356-62.

A decade of percutaneous coronary interventions in cardiac transplant recipients: a monocentric study in 160 patients.
Wellnhofer E, Hiemann NE, Hug J, et al.
J Heart Lung Transplant 2008;27:17-25.

Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.
Weiss ES, Nwakanma LU, Patel ND, Yuh DD.
J Heart Lung Transplant 2008;27:184-91.

Influence of socioeconomic status on survival after primary aortic or mitral valve replacement.
Bagger JP, Edwards MB, Taylor KM.
Heart 2008;94:182-85.

Thromboembolic complications after surgical correction of mitral regurgitation: incidence, predictors, and clinical implications.
Russo A, Grigioni F, Avierinos JF, Freeman WK, et al.
J Am Coll Card 2008;51:1203-11.

Evolving concepts and technologies in mitral valve repair.
Fedak PWM, McCarthy PM, Bonow RO.
Circulation 2008;117:963-74.

Five-year echocardiographic results of combined undersized mitral ring annuloplasty and coronary artery bypass grafting for chronic ischaemic mitral regurgitation.
Gelsomino S, Lorusso R, De Cicco G, et al.
Eur Heart J 2008;29:231-40.